NGMBIO
Live / Applied — Fourth extension granted (statement of use) (as of 12 May 2025)
What this means for you
Not registered yet, but its 15 Nov 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97124968
- Mark type
- Word mark
- Filed
- 15 Nov 2021
- Published for opposition
- 09 May 2023
- Attorney of record
- Anna E. Raimer
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
- Class 044 — Medical, beauty and agricultural services: Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases
Owner
- NGM Biopharmaceuticals, Inc., South San Francisco, CA, US
- NGM Biopharmaceuticals, Inc., South San Francisco, CA, US
Prior registrations
Prosecution history
- 01 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Nov 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 24 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 May 2025 — SOU EXTENSION 4 GRANTED
- 12 May 2025 — SOU EXTENSION 4 FILED
- 12 May 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2024 — SOU EXTENSION 3 GRANTED
- 18 Nov 2024 — SOU EXTENSION 3 FILED